Literature DB >> 21702041

Alcohol drinking and primary liver cancer: a pooled analysis of four Japanese cohort studies.

Taichi Shimazu1, Shizuka Sasazuki, Kenji Wakai, Akiko Tamakoshi, Ichiro Tsuji, Yumi Sugawara, Keitaro Matsuo, Chisato Nagata, Tetsuya Mizoue, Keitaro Tanaka, Manami Inoue, Shoichiro Tsugane.   

Abstract

Because studies of the association between alcohol intake and the risk of primary liver cancer use varying cut-off points to classify alcohol intake, it is difficult to precisely quantify this association by meta-analysis of published data. Furthermore, there are limited data for women in prospective studies of the dose-specific relation of alcohol intake and the risk of primary liver cancer. We analyzed original data from 4 population-based prospective cohort studies encompassing 174,719 participants (89,863 men and 84,856 women). After adjustment for a common set of variables, we used Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of primary liver cancer incidence according to alcohol intake. We conducted a meta-analysis of the HRs derived from each study. During 1,964,136 person-years of follow-up, 804 primary liver cancer cases (605 men and 199 women) were identified. In male drinkers, the multivariate-adjusted HRs (95% CI) for alcohol intakes of 0.1-22.9, 23.0-45.9, 46.0-68.9, 69.0-91.9 and ≥92.0 g/day, as compared to occasional drinkers, were 0.88 (0.57-1.36), 1.06 (0.70-1.62), 1.07 (0.69-1.66), 1.76 (1.08-2.87) and 1.66 (0.98-2.82), respectively (p for trend = 0.015). In women, we observed a significantly increased risk among those who drank ≥23.0 g/day, as compared to occasional drinkers (HR: 3.60; 95% CI: 1.22-10.66). This pooled analysis of data from large prospective studies in Japan indicates that avoidance of (1) heavy alcohol drinking (≥69.0 g alcohol/day) in men and (2) moderate drinking (≥23.0 g alcohol/day) in women may reduce the risk of primary liver cancer.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21702041     DOI: 10.1002/ijc.26255

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

2.  Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid diet.

Authors:  Kelly E Mercer; Casey F Pulliam; Kim B Pedersen; Leah Hennings; Martin Jj Ronis
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

3.  Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality.

Authors:  E Christina Persson; Lauren M Schwartz; Yikyung Park; Britton Trabert; Albert R Hollenbeck; Barry I Graubard; Neal D Freedman; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-10       Impact factor: 4.254

4.  Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male Mice.

Authors:  Kelly E Mercer; Casey Pulliam; Leah Hennings; Keith Lai; Mario Cleves; Ellen Jones; Richard R Drake; Martin Ronis
Journal:  Cancer Prev Res (Phila)       Date:  2016-03-22

5.  Risk of lung cancer and consumption of vegetables and fruit in Japanese: A pooled analysis of cohort studies in Japan.

Authors:  Kenji Wakai; Yumi Sugawara; Ichiro Tsuji; Akiko Tamakoshi; Taichi Shimazu; Keitaro Matsuo; Chisato Nagata; Tetsuya Mizoue; Keitaro Tanaka; Manami Inoue; Shoichiro Tsugane; Shizuka Sasazuki
Journal:  Cancer Sci       Date:  2015-07-24       Impact factor: 6.716

6.  Alcohol consumption, one-carbon metabolites, liver cancer and liver disease mortality.

Authors:  Lauren M Schwartz; E Christina Persson; Stephanie J Weinstein; Barry I Graubard; Neal D Freedman; Satu Männistö; Demetrius Albanes; Katherine A McGlynn
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

7.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

8.  Alcohol consumption and mortality in the Korean Multi-Center Cancer Cohort Study.

Authors:  En-Joo Jung; Aesun Shin; Sue K Park; Seung-Hyun Ma; In-Seong Cho; Boyoung Park; Eun-Ha Lee; Soung-Hoon Chang; Hai-Rim Shin; Daehee Kang; Keun-Young Yoo
Journal:  J Prev Med Public Health       Date:  2012-09-28

9.  Physical activity and risk of fatty liver in people with different levels of alcohol consumption: a prospective cohort study.

Authors:  Kenji Tsunoda; Yuko Kai; Ken Uchida; Tsutomu Kuchiki; Toshiya Nagamatsu
Journal:  BMJ Open       Date:  2014-08-05       Impact factor: 2.692

10.  Plasma Folate and Vitamin B12 Levels in Patients with Hepatocellular Carcinoma.

Authors:  Lian-Hua Cui; Zhen-Yu Quan; Jin-Mei Piao; Ting-Ting Zhang; Meng-Hui Jiang; Min-Ho Shin; Jin-Su Choi
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.